scorecardresearch
Follow Us:
Tuesday, June 15, 2021

cipla

CIPLA NEWS

Pfizer, Cipla demands pending, DCGI relaxes norms for clearing vaccines

June 02, 2021 7:20 am

The move, which would make it easier for companies to bring their vaccines to India, follows similar demands raised by, among others, Pfizer and Cipla during negotiations to supply imported vaccines to the country.

Cipla launches RT-PCR test kit 'ViraGen' in India partnership with Ubio Biotech

May 20, 2021 1:14 pm

Cipla will launch ViraGen test kit in the country in partnership with Ubio Biotechnology Systems, the company stated.

Maharashtra: FIR against unidentified persons posing as Cipla representatives

May 14, 2021 12:44 am

The pharmaceutical company alleged the accused were putting up posts on various social media platforms to lure people in need of the much-sought-after drugs.

Karnataka issues notices to Cipla, Jubilant pharma companies for 'failing to supply' Remdesivir

May 12, 2021 10:10 am

The companies have failed to "supply the requisite quantity as directed by the Government of India, which has severely impacted the treatment of patients requiring Remdesivir vials in the state," the notice reads.

Beware of fraudsters posing as Cipla representatives: Mumbai police

May 01, 2021 5:46 am

Cipla pharmaceutical company has submitted a formal complaint to the Mumbai Cyber Police in the regard.

Cipla ties up with MSD to make, distribute investigational drug molnupiravir in India

April 28, 2021 11:27 pm

The MSD is developing molnupiravir in collaboration with Ridgeback Biotherapeutics. This agreement is a part of Cipla's efforts to enhance global access to treatment for patients affected by the pandemic.

Cipla partners Premier Medical Corporation to launch COVID-19 rapid antigen test kits in India

December 16, 2020 12:53 pm

The company said it will commence supply of rapid point-of-care nasopharyngeal swab tests from this week.

Cipla shares rally 10% after Q1 earnings

August 10, 2020 1:12 pm

Cipla stock zoomed 9.99 per cent to Rs 801.45 -- its 52-week high -- on the BSE. It rose sharply by 9.99 per cent to its one-year high of Rs 801.50 on the NSE.

Collaborating with govt agencies to develop treatment for COVID-19: Cipla

August 05, 2020 5:00 pm

The Mumbai-based drug firm is also ramping up manufacturing of essential drugs required in the fight against the pandemic.

Cipla set to undercut rivals with generic remdesivir for Covid treatment: Sources

July 09, 2020 7:21 am

Cipla India business chief executive officer and executive vice president Nikhil Chopra said in an emailed statement that the company was launching Cipremi commercially on Wednesday and aims to supply over 80,000 vials within the first month, but did not give details on pricing or dosage.